OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Indexing: DOAJ-Directory of Open Access Journals.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2020, 1-2 days of FREE language polishing time is also included in this period). A first decision provided to authors of manuscripts submitted to this journal are approximately 3.3 weeks (median values) after submission.
Geriatric Cardiac Diseases
Submission Deadline: February 15, 2021 (Open) Submit Now
Giuseppe Cocco, MD
Emeritus Professor, Emeritus Fellow of the European Society of Cardiology, Cardiology Office, Marktgasse 10a, CH-4310 Rheinfelden, Switzerland
Research Interests: Geriatric cardiology; old cardiac patients; heart failure; geriatric cardiac diseases; noninvasive cardiovascular diagnostics and cardiovascular therapeutics
About This Topic
The special issue entitled "Geriatric Cardiac Diseases" aims to cover the latest and outstanding developments in the field of geriatric cardiac disease, focusing on known-unknowns in the diagnosis and therapeutics of this increasingly frequent pathology. The issue presents the specific characteristics of the elderly cardiac patients, dealing with prevention, the therapy of arterial hypertension, of arrhythmias (especially atrial fibrillation), of coronary artery syndromes, of valve heart diseases, and of heart failure. We will welcome research articles, review articles, editorials, case reports, perspectives, etc. The editor hopes that readers of this issue of the "Geriatric Cardiac Diseases" will find it of interest.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.